with skin photosensitivity often exceeding 6 weeks (Doughertv et al. 1990). The most significant morbidity from photodynamic treatment of the bladder arises. however. from the relatixve lack of selectivity of haematoporphynn-based sensitizers between mucosa and detrusor muscle. Furthermore. intravesical administration is unreliable with these photosensitizers. and this also means that the transitional cell layer cannot act as a natural barrier to the uptake of (Chang et al. 1996b).
Photodvnamic therapx (PDT) is a method for the treatment of cancer based on the svstemic or topical administration of drugrs called photosensitizers. which are activated in the presence of light to cause cell death and tissue destruction. Ideally. photosensitizers should be selectively retained by tumour. leaving adjacent tissue undamaged following, light activation. although in practice this has been difficult to attain (Bown. 1989) .
Transitional cell carcinomas (TCCs) of the bladder are ideal for this type of treatment because. with careful control of the lirht distribution. curative doses can reach all parts of the urothelial surface (D'Hallewin et al. 1992) . This is of importance in problematic superficial tumours. which are often multifocal. Areas of poorly defined dysplasia and carcinoma in situ are therefore amenable to effective photodynamic therapy.
First-generation sensitizers. such as haematoporphyrin derivative. are usually administered systemically. This results in the inevitable distribution of drug to various organs such as the skin.
with skin photosensitivity often exceeding 6 weeks (Doughertv et al. 1990 ). The most significant morbidity from photodynamic treatment of the bladder arises. however. from the relatixve lack of selectivity of haematoporphynn-based sensitizers between mucosa and detrusor muscle. Furthermore. intravesical administration is unreliable with these photosensitizers. and this also means that the transitional cell layer cannot act as a natural barrier to the uptake of (Benson. 1988) . Partly as a result of this. photodynamic therapy of the bladder using first-generation sensitizers has been associated with serious damage to. and therefore functional impairment of. the detrusor muscle (Nseyo et al. 1985) .
The use of an endogenous substance. 5-aminolaev-ulinic acid (ALA). to generate the synthesis in situ of the pure porphyrin. protoporphyrin IX (PpLX) with minimal toxicity. represents a new strategy in the administration of photosensitizing drugs. ALA. a natural precursor of haem. is a low-molecular weight substance which is taken up by all nucleated cells. The immediate precursor of haem is PpIX and. because this final step is rate-limiting.
exogenous ALA results in the accumulation of PpIX. which is an effective photosensitizer which can be exploited for photodynamic therapy. Intravenous administration of ALA results in rapid clearance from the body. with no detectable PpIX fluorescence in the skin or other organs after 24 h (Kennedy et al. 1991 ) . It has been previously demonstrated (Steinbach et al. 1994) . using qualitative measures. that intravesical ALA in human subjects can induce selective porphyrin accumulation within bladder tumour. compared with normal urothelium and detrusor muscle. Studies of intravesical ALA in the rat bladder confirm that selective accumulation of sensitizer was 11 times greater than in detrusor muscle (Chang et al. 1996a ). The importance of mucosal selectivity was demonstrated by showing that subsequent photodynamic damage to the bladder wall was minimal (Chang et al. 1996b ). were taken for full blood count and baseline plasma porphyrin lexels and serum samples for urea and electrolyrtes and liver function tests. Total plasma porphvrins A ere determined spectrofluorometrically. In six patients. uroflowx parameters w-ere measured before instillation using a urine flowx meter. and the post-micturitional residual estimated using an ultrasound scanner (Bard Bladderscan).
Instillation of intravesical ALA Between 2 and 5 h preoperatively. 50 ml of 3%le ALA (Sigma) was instilled intravesical1v Xia a 12-F Lofric catheter. The solution w-as prepared by dissolvinc 1.5 g of ALA in 50 ml of physiological saline buffered to a pH of 6.5 with 8.4%-sodium bicarbonate. The solution A as freshly prepared and sterilized by ultrafiltration at the Department of Pharmacy of the University Hospital. Cardiff. UK. Solutions of ALA were instilled w-ithin 3 h of preparation and refrigerated in the dark-until used.
Fluorescence cystoscopy
Under spinal or general anaesthesia. all instilled ALA w as drained and subsequent cystoscopy carried out using sterile 1.5%e glNcine. Conventional cystoscopy A-ith w-hite light w-as briefly carried out. followed by fluorescence cystoscopy. This has previously been descnrbed to determine qualitatively the preferential nature of ALA fluorescence kinetics within tumour and for possible early detection of bladder cancer (Kriegmair et al. 1994 (Kriegmair et al. . 1996a 
RESULTS

Results of in vitro fluorescence kinetics of ALAmediated accumulation of PpIX
Incubation of tissue samples in ALA resulted in an initial timedependent increase in tissue fluorescence for all three tissue ty pes over the first 2-6 h. Howexer. the increase in detrusor muscle tissue fluorescence w-as relatively small compared w-ith that of tumour and normal urothelial tissue. The peak-fluorescence in tumour tissue was double that of normal urothelium and nearly six times that of detrusor muscle. Tumour fluorescence appeared to peak between 2 and 6 h of incubation in ALA. but. by 24 h. this had diminished to fluorescence levels similar to those of normal urothelium and detrusor muscle (Ficure 1).
Results of in vivo study Results of fluorescence cystoscopy
Of ten patients in whom intravesical ALA A-as administered. eight had evaluable superficial bladder tumours. Cystoscopx of these patients using the violet excitation light source resulted in bright red fluorescence of all tumours identified using conventional A hite light. In one patient. conventional cystoscopy revealed a flat. red area of bladder which did not fluoresce when the light source was sw itched. This area A-as biopsied and subsequent histological examination confirmed features consistent with chronic inflammation. In a second patient with a previous history of carcinoma in situ. however. w-hite light cystoscopy A-as unremark-able although an area near the trigone fluoresced brightly. This area w as biopsied colleagues (Kriegmair et al. 1994 . 1996a PpIX accumulation within the X arious tissues has been well described and A-as carried out using, fluorescence microscopy. utilizing a highly sensitive CCD camera (Bedwell et al. 1992 : Regula et al. 1995 . Loh et al (1993) were able to show. using in patients with carcinoma in situ (D'Hallewin and Marijnissen. 1995 (Chang et al. 1996b ). The opportunity of administering ALA intravesically not onlv allows the urothelium to act as a potential barrier to sensitizer accumulation within detrusor. but also theoreticallv reduces the risk of skin photosensitivity. assuming that there is minimal absorption of ALA by the transitional cell laver. It has been demonstrated qualitativelv that intravesical ALA in human subjects induces photosensitizer uptake within normal and neoplastic urothelium. with minimal detrusor accumulation (Steinbach et al. 1994) . Using a krypton laser to induce fluorescence rather than tumour destruction. the same group has exploited the preferential accumulation of sensitizer within tumour as a diagnostic tool to enhance cystoscopic visualization of poorly defined dysplasias and carcinomas in situ (Kriegmair et al. 1994 . 1 996a). However. these studies were confined to establishina the qualitative differences between ALAinduced fluorescence in tumour and non-tumour tissue. W'e have been able to reproduce the technique of fluorescence cystoscopy. and also determine. quantitatively. that ALA-mediated fluorescence is up to 11 times greater in transitional cell tumour compared with normal urothelium. The fluorescence intensity-within the Various tumour specimens is summarized in Table 1 . There does not appear to be a clear difference between patients with moderatelv differentiated or well-differentiated tumours.
To date. there is only one report of ALA-mediated photodynamic therapy of bladder cancer in patients ( Kriegmair et al. 1996b 
